Patients with AML-MRC: breakdown by WHO qualification criteria
| Parameter . | No of cases (%) . |
|---|---|
| MLD sole | 90 (51.4) |
| MDS related cytogenetics (MRC) sole | 25 (14.3) |
| History of MDS or MDS/MPN-sole | 11 (6.3) |
| MLD + preexisting MDS | 22 (12.6) |
| MLD + MDS-related cytogenetics | 22 (12.6) |
| MLD + MDS-related cytogenetics + preexisting MDS/MPN | 2 (1.1) |
| MDS related cytogenetics + preexisting MDS/ MPN | 3 (1.7) |
| Total | 175 (100.0) |
| Parameter . | No of cases (%) . |
|---|---|
| MLD sole | 90 (51.4) |
| MDS related cytogenetics (MRC) sole | 25 (14.3) |
| History of MDS or MDS/MPN-sole | 11 (6.3) |
| MLD + preexisting MDS | 22 (12.6) |
| MLD + MDS-related cytogenetics | 22 (12.6) |
| MLD + MDS-related cytogenetics + preexisting MDS/MPN | 2 (1.1) |
| MDS related cytogenetics + preexisting MDS/ MPN | 3 (1.7) |
| Total | 175 (100.0) |